Relevance to NICE guidance programmes

Relevance to NICE guidance programmes

Aripiprazole prolonged-release injection was not considered appropriate for a NICE technology appraisal, and is not currently planned into any other work programme.

In February 2014, NICE published Psychosis and schizophrenia in adults: treatment and management (NICE clinical guideline 178). NICE has also published a technology appraisal for oral aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years (NICE technology appraisal guidance 213).